Table 2 Backgrounds of patients with chronic liver diseases.
N = 81 | ||
|---|---|---|
Age: years, mean ± SD | 75 ± 11 | |
Men: n (%) | 54 (67%) | |
BMI, mean ± SD | 22 ± 3.7 | |
Performance status: n (%) | 0/1/2/3/4 | 19/31/21/8/2 (23/38/26/10/3%) |
%AC: %, mean ± SD | 90 ± 13 | |
%AMC: %, mean ± SD | 95 ± 14 | |
%AMA: %, mean ± SD | 70 ± 28 | |
HCC: n (%) | 54 (67%) | |
Etiology: n (%) | HBV | 5 (6.6%) |
HCV | 39 (48%) | |
Alcohol | 16 (20%) | |
NASH | 19 (23%) | |
AIH | 1 (1.2%) | |
PBC | 1 (1.2%) | |
Child–Pugh grade: n (%) | A/B/C | 39/32/10 (48/40/2%) |
Ascites: n (%) | 18 (22%) | |
Comorbidities: n (%) | Heart disease | 13 (16%) |
Chronic lung disease | 8 (9.9%) | |
Cerebrovascular disease | 4 (4.9%) | |
Chronic renal disease | 6 (7.4%) | |
Diabetes | 23 (28%) | |
Oral medication: n (%) | BCAA | 24 (30%) |
Diuretics | 31 (38%) | |
Carnitine | 6 (7.4%) | |
Myopenia: n (%) | By PMI | 29 (36%) |
By simple PMI | 23 (28%) | |
By AMA | 29 (36%) | |
Albumin: g/dl, mean ± SD | 3.4 ± 0.75 | |
Total cholesterol: mg/dl, mean ± SD | 179 ± 59 | |
Total bilirubin: g/dl, mean ± SD | 1.5 ± 1.5 | |
γ-GTP: U/l, mean ± SD | 140 ± 231 | |
White blood cell: × 103/μl, mean ± SD | 5.9 ± 2.8 | |
Hemoglobin: g/dl, mean ± SD | 12 ± 2.2 | |
Platelet: × 103/μl, mean ± SD | 157 ± 103 | |
Neutrophil: %, mean ± SD | 67 ± 13 | |
Lymphophil: %, mean ± SD | 23 ± 11 | |
Prothrombin time: %, mean ± SD | 80 ± 16 |
